-
EP1226269
European procedure
Extract from the Register of European Patents
EP About this file: EP1226269
| EP1226269 - ASSAY [Right-click to bookmark this link] | |||
| Former [2002/31] | REVERSED-PHASE HPLC ASSAY FOR PLASMINOGEN ACTIVATORS | ||
| [2002/51] | Status | No opposition filed within time limit Status updated on 23.04.2004 Database last updated on 04.06.2024 | Most recent event Tooltip | 15.08.2008 | Change - representative | published on 17.09.2008 [2008/38] | Applicant(s) | For all designated states Genentech, Inc. 1 DNA Way South San Francisco, CA 94080-4990 / US | [N/P] |
| Former [2002/31] | For all designated states Genentech, Inc. 1 DNA Way South San Francisco, CA 94080-4990 / US | Inventor(s) | 01 /
XU, Yuan 511 Seastorm Drive Redwood City, CA 94065 / US | [2002/31] | Representative(s) | Wichmann, Hendrik, et al Patentanwälte Isenbruck Bösl Hörschler PartG mbB Prinzregentenstrasse 68 81675 München / DE | [N/P] |
| Former [2008/38] | Wichmann, Hendrik, et al Isenbruck Bösl Hörschler Wichmann Huhn Patentanwälte Prinzregentenstrasse 68 81675 München / DE | ||
| Former [2003/12] | Wichmann, Hendrik, Dr., et al Patentanwälte Isenbruck Bösl Hörschler Wichmann Huhn Postfach 86 08 80 81635 München / DE | ||
| Former [2002/31] | Wichmann, Hendrik, Dr. Patent- und Rechtsanwälte Bardehle - Pagenberg - Dost Altenburg - Geissler - Isenbruck, Galileiplatz 1 81679 München / DE | Application number, filing date | 00978343.2 | 01.11.2000 | [2002/31] | WO2000US30252 | Priority number, date | US19990163607P | 04.11.1999 Original published format: US 163607 P | [2002/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0132915 | Date: | 10.05.2001 | Language: | EN | [2001/19] | Type: | A2 Application without search report | No.: | EP1226269 | Date: | 31.07.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.05.2001 takes the place of the publication of the European patent application. | [2002/31] | Type: | B1 Patent specification | No.: | EP1226269 | Date: | 18.06.2003 | Language: | EN | [2003/25] | Search report(s) | International search report - published on: | EP | 07.03.2002 | Classification | IPC: | C12Q1/56, C12Q1/37, C12N9/72 | [2002/31] | CPC: |
C12Q1/37 (EP,US);
G01N30/02 (EP,KR,US);
G01N2333/9726 (EP,US)
| C-Set: |
G01N30/02, B01D15/325 (EP,US)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/31] | Extension states | AL | 23.04.2002 | LT | 23.04.2002 | LV | 23.04.2002 | MK | 23.04.2002 | RO | 23.04.2002 | SI | 23.04.2002 | Title | German: | TESTVERFAHREN | [2002/51] | English: | ASSAY | [2002/51] | French: | ESSAI | [2002/51] |
| Former [2002/31] | "REVERSED-PHASE-HPLC" FÜR PLASMINOGEN-AKTIVATOREN | ||
| Former [2002/31] | REVERSED-PHASE HPLC ASSAY FOR PLASMINOGEN ACTIVATORS | ||
| Former [2002/31] | METHODE DE CHROMATOGRAPHIE LIQUIDE A HAUTE PERFORMANCE EN PHASE INVERSE POUR ACTIVATEURS DE PLASMINOGENE | Entry into regional phase | 23.04.2002 | National basic fee paid | 23.04.2002 | Designation fee(s) paid | 23.04.2002 | Examination fee paid | Examination procedure | 01.06.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 23.04.2002 | Examination requested [2002/31] | 21.11.2002 | Communication of intention to grant the patent | 31.03.2003 | Fee for grant paid | 31.03.2003 | Fee for publishing/printing paid | Opposition(s) | 19.03.2004 | No opposition filed within time limit [2004/24] | Fees paid | Renewal fee | 13.11.2002 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO8904367 (GENENTECH INC [US]) [AD] 1-11 * the whole document *; | US5411864 [ ] (ANICETTI VINCENT R [US], et al); | [A] - APFFEL A ET AL, "Application of new analytical technology to the production of a "well-characterized biological".", DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION, Symposium;Washington, D.C., USA; December 11-13, 1995, biotechnology pharmaceutical products. 1998 S. Karger AG; S. Karger AG P.O. Box, Allschwilerstrasse 10, CH-4009 Basel, Switzerland; New York, New York, USA, (1998), vol. 96, ISBN 3-8055-6805-3, pages 11 - 25, XP001006250 [A] 1-11 * the whole document * | [A] - ANCINETTI, V AND HANCOCK,WS, "Analytical considerations in the development of protein purification processes", BIOPROCESS. TECHNOL., (1994), vol. 18, pages 11 - 36, XP001006204 [A] 1-11 * page 28, line 10 - page 29, line 2; figure 3 * |